You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金活醫藥集團(01110.HK)上半年公司擁有人應占溢利預增95%-100%
格隆匯 08-16 22:05

格隆匯8月16日丨金活醫藥集團(01110.HK)公佈,集團預期於截至2021年6月30日止6個月的公司擁有人應占溢利將較截至2020年6月30日止六個月("前期間")的人民幣990萬元增加約95%至100%。

董事會認為公司擁有人應占溢利增加主要是由於從事品牌進口醫藥及保健產品的中國分銷業務之收入及毛利因COVID-19疫情受到控制,使市場在該期間相對前期間有所復甦而分別增加約90%至95%及約130%至135%。

公司非全資附屬公司深圳市東迪欣科技有限公司("東迪欣"),一家生產各種醫療設備(包括紅外線探熱器)的醫療設備製造商,並已為其製造的醫療設備取得各項證書及許可證,預期於該期間的期內溢利將較前期間減少約33%至38%主要是由於抗疫情設備的銷售有所回落所致。

基於上文所述,集團預期該期間的集團期內溢利將較前期間的人民幣3180萬元增加約5%至10%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account